Immunological Biomarkers for Diabetes Management (original) (raw)

2019

Abstract

Globally there are 422 million known cases of people affected with diabetes according to the world health organisation (1). It is estimated that 46% of people with diabetes worldwide are undiagnosed (2). Monitoring diabetes and improving life style for such patients is also a big challenge for current healthcare. To address this global health issue, we have investigated immunological serum and salivary biomarkers for diabetes using molecular arrays, namely cytokine and growth factor kit I from Randox Laboratories Ltd, London, UK

Ruta Furmonaviciene hasn't uploaded this paper.

Let Ruta know you want this paper to be uploaded.

Ask for this paper to be uploaded.